Hindustan Bio Sciences
7.85
+0.02(+0.26%)
Market Cap₹8.02 Cr
PE Ratio-97.88
Company Performance:
1D+0.26%
1M-13.36%
6M+31.49%
1Y-19.49%
5Y+106.04%
View Company Insightsright
More news about Hindustan Bio Sciences
23Jan 26
Hindustan Bio Sciences Limited Reports Substantial Share Acquisition by Bosco Armando Menezes & Emily Bosco Menezes
Hindustan Bio Sciences Limited reported a substantial share acquisition by Bosco Armando Menezes and Emily Bosco Menezes under SEBI regulations. The non-promoter acquirers purchased 15,000 shares through open market transactions on January 22, 2026, increasing their combined holding from 4.98% to 5.12% of the company's voting capital. The company's equity structure remains unchanged at Rs.2,05,01,600 consisting of 1,02,50,800 shares of Rs.2 each.
 no imag found
31Jul 25
Hindustan Bio Sciences Reports Q1 Results, Appoints New Company Secretary
Hindustan Bio Sciences Ltd. reported Q1 FY2026 financial results with revenue from operations at Rs. 32.19 lakhs, down from previous periods but maintaining profitability at Rs. 1.40 lakhs. The company announced management changes with Mr. Devanshu Ravinder Dange resigning as Company Secretary and Mr. Shailendra Vyas appointed as the new Company Secretary, effective August 1. The board also approved various corporate governance matters including the notice for the 33rd AGM and adoption of the Secretarial Audit Report.
 no imag found
Hindustan Bio Sciences
7.85
+0.02
(+0.26%)
1 Year Returns:-19.49%
Industry Peers
Tanla Platforms
528.30
(-2.72%)
CE Info Systems
815.90
(-1.17%)
Moschip Technologies
215.15
(-1.43%)
TechNVision Ventures
5,105.50
(-5.45%)
Nucleus Software
727.05
(-1.04%)
Ramco Systems
448.05
(-2.82%)